Detailed Narrative
Robust FY25 Performance and Strategic Growth Drivers
India Pesticides reported a strong FY25 with revenue growing 21.3% YoY to INR 844 crore and EBITDA increasing 32% to INR 134 crore, achieving a 16% margin. This performance was driven by strategic clarity, effective execution, and a differentiated product portfolio. Management highlighted increased capacity utilization, new product introductions, and backward integration as key drivers for future growth, aiming for INR 1,000 crore revenue and 18-20% EBITDA margin in FY26.
Capacity Expansion and Debt-Free Commitment
The company has planned a capex of INR 116 crore for FY26, with over INR 200 crore projected over two years, focusing on existing facilities and Shalvis Specialities Limited. This includes INR 52 crore for the existing facility and INR 64 crore for Shalvis, along with investments in a boiler and new production complexes at Sandila. Despite these investments, IPL remains committed to maintaining a debt-free position, funding all expansions through internal accruals.
Formulations and Pretilachlor as Key Growth Engines
The formulations business demonstrated strong growth, exceeding 20% compounded, with bulk formulation exports increasing significantly from INR 10-12 crore to INR 50 crore. Pretilachlor, a major rice herbicide, is expected to see significant jumps with 20% compounded growth over the next 2-3 years, driven by increased capacity. The company anticipates over INR 100 crore in sales from Pretilachlor in FY25, with its 8,500-ton capacity potentially generating over INR 300 crore.
Market Diversification and Regulated Market Penetration
IPL is broadening its market reach, establishing a stronger presence in over 25 regulated markets. In FY25, the company secured 4 technical and 19 formulation registrations in India, along with 4 registrations in EU/UK and 2 in USA, plus 2 formulation registrations in Australia. Commercial supplies for one US-registered product have already begun, with orders expected for another soon, reinforcing IPL's position as a reliable global partner.
Working Capital and Cash Flow Management
Operating cash flow for FY25 was significantly low at INR 2 crore, primarily due to an increase in debtor levels as some large buyers remitted payments in April instead of March. Additionally, IPL strategically increased inventory to cater to MNC customers with shorter order cycles and avoid losing seasonal demand. Management expects working capital days to normalize from ~250 days to ~220 days in the coming quarters⏳.
Raw Material Stability and Margin Improvement Outlook
After a period of drastic price reductions in the previous year, raw material prices are now stabilizing, contributing to margin expansion. Management attributes the projected improvement in EBITDA margins from 16% to 18-20% in FY26 to operating leverage, the introduction of new products, and backward integration initiatives. They also noted that domestic and export margins are largely on par, with minor differences related to imported raw material duties.